These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 33673694)

  • 1. Oxytocin and Addiction: Potential Glutamatergic Mechanisms.
    Sundar M; Patel D; Young Z; Leong KC
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of oxytocin in alcohol and drug abuse.
    King CE; Gano A; Becker HC
    Brain Res; 2020 Jun; 1736():146761. PubMed ID: 32142721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuated cocaine-seeking after oxytocin administration in male and female rats.
    Kohtz AS; Lin B; Smith ME; Aston-Jones G
    Psychopharmacology (Berl); 2018 Jul; 235(7):2051-2063. PubMed ID: 29671014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxytocin treatment in the prelimbic cortex reduces relapse to methamphetamine-seeking and is associated with reduced activity in the rostral nucleus accumbens core.
    Everett N; Baracz S; Cornish J
    Pharmacol Biochem Behav; 2019 Aug; 183():64-71. PubMed ID: 31202809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rebalancing the Addicted Brain: Oxytocin Interference with the Neural Substrates of Addiction.
    Bowen MT; Neumann ID
    Trends Neurosci; 2017 Dec; 40(12):691-708. PubMed ID: 29128108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent updates on incubation of drug craving: a mini-review.
    Li X; Caprioli D; Marchant NJ
    Addict Biol; 2015 Sep; 20(5):872-6. PubMed ID: 25440081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date.
    Lee MR; Rohn MC; Tanda G; Leggio L
    CNS Drugs; 2016 Feb; 30(2):109-23. PubMed ID: 26932552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of neuroimmune signaling and glutamate plasticity in addiction.
    Gipson CD; Rawls S; Scofield MD; Siemsen BM; Bondy EO; Maher EE
    J Neuroinflammation; 2021 Feb; 18(1):56. PubMed ID: 33612110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxytocin signaling in the treatment of drug addiction: Therapeutic opportunities and challenges.
    Che X; Cai J; Liu Y; Xu T; Yang J; Wu C
    Pharmacol Ther; 2021 Jul; 223():107820. PubMed ID: 33600854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oxytocin on prosocial behavior and the associated profiles of oxytocinergic and corticotropin-releasing hormone receptors in a rodent model of posttraumatic stress disorder.
    Wang SC; Lin CC; Tzeng NS; Tung CS; Liu YP
    J Biomed Sci; 2019 Mar; 26(1):26. PubMed ID: 30898126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The good and bad news about glutamate in drug addiction.
    Spencer S; Scofield M; Kalivas PW
    J Psychopharmacol; 2016 Nov; 30(11):1095-1098. PubMed ID: 27353027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxytocin and Rodent Models of Addiction.
    Leong KC; Cox S; King C; Becker H; Reichel CM
    Int Rev Neurobiol; 2018; 140():201-247. PubMed ID: 30193705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxytocin Signaling as a Target to Block Social Defeat-Induced Increases in Drug Abuse Reward.
    Ferrer-Pérez C; Reguilón MD; Miñarro J; Rodríguez-Arias M
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of oxytocin in the neuroadaptation to drugs of abuse.
    Sarnyai Z; Kovács GL
    Psychoneuroendocrinology; 1994; 19(1):85-117. PubMed ID: 9210215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate Homeostasis.
    Scofield MD; Heinsbroek JA; Gipson CD; Kupchik YM; Spencer S; Smith AC; Roberts-Wolfe D; Kalivas PW
    Pharmacol Rev; 2016 Jul; 68(3):816-71. PubMed ID: 27363441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of metabotropic glutamate receptors in drug reward, motivation and dependence.
    Markou A
    Drug News Perspect; 2007 Mar; 20(2):103-8. PubMed ID: 17440633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in the glutamate system: Implications for addiction.
    Giacometti LL; Barker JM
    Neurosci Biobehav Rev; 2020 Jun; 113():157-168. PubMed ID: 32173404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oxytocin on methamphetamine-seeking exacerbated by predator odor pre-exposure in rats.
    Ferland CL; Reichel CM; McGinty JF
    Psychopharmacology (Berl); 2016 Mar; 233(6):1015-24. PubMed ID: 26700240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synaptic pathology of drug addiction.
    Van den Oever MC; Spijker S; Smit AB
    Adv Exp Med Biol; 2012; 970():469-91. PubMed ID: 22351069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxytocin inhibits ethanol consumption and ethanol-induced dopamine release in the nucleus accumbens.
    Peters ST; Bowen MT; Bohrer K; McGregor IS; Neumann ID
    Addict Biol; 2017 May; 22(3):702-711. PubMed ID: 26810371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.